15-Nov-2016 | S | Sanguine Media Ltd has informed BSE that the Board of Directors in its meeting held on November 14, 2016, has decided the following matters:
1. Change the face value of equity shares of the Company from Re. 1/- to Rs. 10/- per share.
Trading members of the Exchange are hereby informed that Sanguine Media Limited has fixed the Record Date for the purpose of Consolidation of the equity shares of the company.
Trading members of the Exchange are hereby advised not to deal in the Equity Shares of the Company as per details given below:
COMPANY NAME CODE
Sanguine Media Limited
(531898)
RECORD DATE
20/01/2017
PURPOSE
Consolidation of existing TEN equity shares from Re.1/- each to ONE equity share of Rs.10/- each.
NO DEALINGS FROM
19/01/2017 DR-202/2016-2017
Trading Members of the Exchange are requested to take note of it.
(As Per BSE Notice Dated on 09.01.2017) | 20-Jan-2017 | |
25-Sep-2014 | S | Sanguine Media Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 25, 2014, has decided the following matters:
1. Approved sub-division of equity shares. Every shareholders holding 1 (One) equity share of Rs. 10/- each will be allotted 10 (Ten) equity share of Re. 1/- each.
2. To hold the Shareholders meeting in due course.
Sanguine Media Ltd has informed BSE that the Company has fixed November 21, 2014 as the Record Date for the purpose of sub-division / stock split of Rs. 10/- per share of the Company into the shares of Rs. 1/- each.
(As Per BSE Announcement Dated on 31.10.2014)
SUB. :- Sub Division of equity shares of Sanguine Media Limited (Scrip Code 531898)
Trading Members of the Exchange are hereby informed that, Sanguine Media Limited has fixed the Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Sanguine Media Limited
(531898)
RECORD DATE
21/11/2014
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into TEN equity shares of Re.1/- each.
SUB-DIVIDED PAID-UP VALUE
Re.1/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
20/11/2014 DR- 156/2014- 2015
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re. 1/- paid up w.e.f. 20/11/2014.
ii. ISIN No. INE617F01012 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 20/11/2014.
iii. The new ISIN Number for Re.1/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 31.10.2014) | 21-Nov-2014 | |
06-Jun-2008 | R | SUB. :- Rights issue of Sanguine Media Limited (Scrip Code 531898)
Trading Members of the Exchange are hereby informed that, Sanguine Media Limited has fixed the Record Date for the purpose of Rights
Issue. The transactions in the equity shares of the company should be done on ex-rights basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME
COMPANY NAME CODE
Sanguine Media Limited
531898
RECORD DATE
23/06/2008
PURPOSE
ONE Equity Share of Rs.10/- each for cash at a premium of Rs.13/- per equity share on rights basis for every ONE existing equity share of Rs.10/- each held.
TRANSACTIONS IN EQUITY SHARES ON
Cum-Right basis up to Date & Sett. No.
13/06/2008 DR-052/2008-2009
Ex-Right basis from Date & Sett. No.
16/06/2008 DR-053/2008-2009
The auction in the equity shares of Sanguine Media Limited in Dematerialised Securities - Rolling Settlement Segment on 16/06/2008, 17/06/2008 and 18/06/2008 will be conducted on cum-right
basis. Trading members are, therefore, requested to take abundant precautions while mentioning the rates for offering the equity shares of the said company in auction on the said dates.
The scrip will be in No Delivery from 16/06/2008 (DR-053/2008-2009) to 20/06/2008 (DR-057/2008-2009). | 23-Jun-2008 | 1:1 |
18-Mar-2024 | BC | Intimation of meeting of Independent Directors of the company
Outcome of Meeting of Independent Directors held on March 28, 2024.
(As Per BSE Announcement dated on 28.03.2024) | 28-Mar-2024 | |
31-Jan-2024 | BC | SANGUINE MEDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve 1. Unaudited financial result (UFR) for the | 10-Feb-2024 | |
28-Oct-2023 | BC | SANGUINE MEDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve
1. Unaudited financial result (UFR) for t | 08-Nov-2023 | |
05-Sep-2023 | BC | 1) Appointment of Mr. Chirag Jain, Partner at JCA & Co, as Secretarial Auditor of the company. 2) Director''s Report for the year ended on March 31,2023 and adoption of Secretarial Audit Report pursu | 29-Sep-2023 | |
29-Sep-2023 | BC | Proceeding of 28th Annual General Meeting of the company held on September 29, 2023 at 11:00 AM at the registered office of the company.
| 29-Sep-2023 | |
No Dividends has been declared by Sanguine_Media
No Bonus has been declared by Sanguine_Media
Record Date20-Jan-2017
Split Date19-Jan-2017
Face Value (Before/After)1/10
Record Date21-Nov-2014
Split Date20-Nov-2014
Face Value (Before/After)10/1
RightsRecord Date01 Jan'1900
Ex-Rights Date01 Jan'1900
Premium(Rs.)13
Ratio1:1
Book Closure
28-Mar-2024 | - | Intimation of meeting of Independent Directors of the company
Outcome of Meeting of Independent Directors held on March 28, 2024.
(As Per BSE Announcement dated on 28.03.2024) |
10-Feb-2024 | - | SANGUINE MEDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve 1. Unaudited financial result (UFR) for the |
08-Nov-2023 | - | SANGUINE MEDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve
1. Unaudited financial result (UFR) for t |
29-Sep-2023 | - | 1) Appointment of Mr. Chirag Jain, Partner at JCA & Co, as Secretarial Auditor of the company. 2) Director''s Report for the year ended on March 31,2023 and adoption of Secretarial Audit Report pursu |
29-Sep-2023 | - | Proceeding of 28th Annual General Meeting of the company held on September 29, 2023 at 11:00 AM at the registered office of the company.
|